GO
Loading...

Bristol-Myers Squibb Co

More

  • Final Glance: Pharmaceuticals companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 76 or 1.0 percent, to $76.87. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $49.12. Hospira rose$. 31 or. 6 percent, to $50.78.

  • Midday Glance: Pharmaceuticals companies Tuesday, 22 Jul 2014 | 1:57 PM ET

    Baxter International Inc. rose$. 93 or 1.2 percent, to $77.04. Bristol-Myers Squibb Co. rose$. 41 or. 8 percent, to $49.33. Hospira rose$. 27 or. 5 percent, to $50.74.

  • Early Glance: Pharmaceuticals companies Monday, 21 Jul 2014 | 11:37 AM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $76.15. Bristol-Myers Squibb Co. fell$. 28 or. 6 percent, to $48.84. Hospira fell$. 06 or. 1 percent, to $50.09.

  • Midday Glance: Pharmaceuticals companies Wednesday, 16 Jul 2014 | 2:54 PM ET

    Baxter International Inc. fell$. 23 or. 3 percent, to $76.53. Bristol-Myers Squibb Co. fell$. 08 or. 2 percent, to $48.63. Hospira fell$. 17 or. 3 percent, to $50.58.

  • Early Glance: Pharmaceuticals companies Wednesday, 16 Jul 2014 | 11:11 AM ET

    Baxter International Inc. fell$. 09 or. 1 percent, to $76.67. Bristol-Myers Squibb Co. rose$. 17 or. 3 percent, to $48.88. Hospira rose$. 04 or. 1 percent, to $50.79.

  • Midday Glance: Pharmaceuticals companies Monday, 14 Jul 2014 | 1:29 PM ET

    Baxter International Inc. rose$. 03 or percent, to $76.62. Bristol-Myers Squibb Co. rose$. 28 or. 6 percent, to $48.90. Hospira rose$. 43 or. 8 percent, to $51.25.

  • Early Glance: Pharmaceuticals companies Monday, 14 Jul 2014 | 10:47 AM ET

    Baxter International Inc. rose$. 20 or. 3 percent, to $76.79. Bristol-Myers Squibb Co. fell$. 04 or. 1 percent, to $48.58. Hospira fell$. 03 or percent, to $50.80.

  • Midday Glance: Pharmaceuticals companies Friday, 11 Jul 2014 | 1:37 PM ET

    Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Bristol-Myers Squibb Co. fell$. 07 or. 1 percent, to $48.44. Hospira fell$. 34 or. 7 percent, to $50.72.

  • Early Glance: Pharmaceuticals companies Friday, 11 Jul 2014 | 10:30 AM ET

    Baxter International Inc. fell$. 54 or. 7 percent, to $76.21. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $48.40. Hospira fell$. 22 or. 4 percent, to $50.84.

  • July 1- Bristol-Myers Squibb Co said it was voluntarily recalling six lots of the injectable version of its blood thinner, Coumadin, in the United States, after particulate matter was found in some unreleased samples.

  • NEW YORK, June 25- U.S. stock investors ignored weak economic data and pushed equities higher on Wednesday, as drugmakers' shares rose and a Supreme Court ruling lifted major broadcaster stocks, while German bond yields hit the year's low on safe-haven bids.

  • US STOCKS-Wall St gains with drugmakers, broadcasters Wednesday, 25 Jun 2014 | 5:09 PM ET

    *Monsanto rallies on outlook and stock-repurchase plans. *CBS shares jump after Supreme Court ruling. Shares of CBS jumped 6.2 percent to $62.48 after the U.S. Supreme Court ruled that online TV startup Aereo Inc violates copyright law by using tiny antennas to provide subscribers with broadcast network content via the Internet.

  • US STOCKS-Wall St rises slightly despite weak GDP report Wednesday, 25 Jun 2014 | 1:40 PM ET

    *Monsanto rallies after results; General Mills lower. *Medical Action almost doubles, Owens& Minor to buy.

  • Midday movers: CBS, HBI, MON, BMY, MDCI & More Wednesday, 25 Jun 2014 | 11:28 AM ET

    Take a look at some of Wednesday's midday movers.

  • US STOCKS-Wall St edges higher despite weak GDP report Wednesday, 25 Jun 2014 | 10:27 AM ET

    *Monsanto rallies after results, General Mills lower. NEW YORK, June 25- U.S. stocks edged higher on Wednesday as investors continued to find value in equities over other asset classes despite the latest economic data coming in below expectations.

  • *Investors watching Iraq violence; crude prices rise. *Monsanto rallies after results, General Mills lower. NEW YORK, June 25- U.S. stock index futures pointed to a lower open on Wednesday as the latest economic data came in below expectations, giving investors further reasons to take profits amid ongoing tension in Iraq.

  • US STOCKS-Futures flat after decline, GDP data awaited Wednesday, 25 Jun 2014 | 7:39 AM ET

    *Investors watching Iraq tension, crude oil rises early. Durable goods orders, also due at 8:30 a.m., are seen as flat in May, while a June read on service sector business activity from financial data firm Markit is seen as essentially unchanged from May.

  • June 24- A late-stage trial testing Bristol-Myers Squibb Co's cancer immunotherapy nivolumab in advanced melanoma patients was halted early after it was determined that the drug was likely to prolong survival, the company said on Tuesday.

  • Check out which companies are making headlines after the bell Tuesday.

  • *$46 bln offer from AbbVie rejected as undervaluing group. LONDON, June 23- Shire flagged the promise of existing and new drugs on Monday as evidence that AbbVie's $46 billion offer undervalued the company, the latest British firm to be targeted by a U.S. group seeking lower taxes.